Cochrane · systematic review · CD012663

Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer

Drost, FJH, Osses, DF, Nieboer, D, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

UrologyAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
26
current version
GRADE rated
17
No studies
4
Included studies
NR
No studies 4 · 15.4%Ungraded 5 · 19.2%Very low 0 · 0%Low 14 · 53.8%Moderate 2 · 7.7%High 1 · 3.8%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Detecting ISUP grade 2 or higher prostate cancer by MRI, MRI‐targeted biopsy, MRI‐pathway and systematic biopsy

6 questions
OutcomeEffectEvidenceStatus / GRADE
Tests
no estimate extractedNRHigh
MRI
no estimate extracted12 studies · 3091 participantsUngraded
MRI‐TBx
no estimate extracted8 studies · 1553 participantsUngraded
MRI pathway
no estimate extracted8 studies · 2257 participantsUngraded
SBx
no estimate extracted4 studies · 3421 participantsUngraded
MRI pathwayvs SBx
no estimate extracted25 studies · 6944 participantsUngraded

Should MRI be used to diagnose ISUP grade ≥ 2 prostate cancer in men suspected of having clinically significant prostate cancer?

Population: men suspected of having clinically significant prostate cancer undergoing their first biopsy (biopsy‐naïve men) or a repeat biopsy (prior‐negative biopsy men)
5 questions
OutcomeEffectEvidenceStatus / GRADE
Test result
no estimate extractedNRNo studies
True positives
no estimate extracted12 studies · 3091 participantsLow
False negatives
no estimate extracted12 studies · 3091 participantsLow
True negatives
no estimate extracted12 studies · 3091 participantsLow
False positives
no estimate extracted12 studies · 3091 participantsLow

Should MRI‐targeted biopsy be used to diagnose ISUP grade ≥ 2 prostate cancer in men suspected of having clinically significant prostate cancer?

Population: men with a positive MRI suspected of having clinically significant prostate cancer undergoing their first biopsy (biopsy‐naïve men) or a repeat biopsy (prior‐negative biopsy men)
5 questions
OutcomeEffectEvidenceStatus / GRADE
Test result
no estimate extractedNRNo studies
True positives
no estimate extracted8 studies · 1553 participantsLow
False negatives
no estimate extracted8 studies · 1553 participantsLow
True negatives
no estimate extracted8 studies · 1553 participantsLow
False positives
no estimate extracted8 studies · 1553 participantsLow

Should an MRI‐pathway be used to diagnose ISUP grade ≥ 2 prostate cancer in men suspected of having clinically significant prostate cancer?

Population: men suspected of having clinically significant prostate cancer undergoing their first biopsy (biopsy‐naïve men) or a repeat biopsy (prior‐negative biopsy men)
5 questions
OutcomeEffectEvidenceStatus / GRADE
Test result
no estimate extractedNRNo studies
True positives
no estimate extracted8 studies · 2257 participantsLow
False negatives
no estimate extracted8 studies · 2257 participantsLow
True negatives
no estimate extracted8 studies · 2257 participantsLow
False positives
no estimate extracted8 studies · 2257 participantsLow

Should systematic biopsy be used to diagnose ISUP grade ≥ 2 prostate cancer in men suspected of having clinically significant prostate cancer?

Population: men suspected of having clinically significant prostate cancer undergoing their first biopsy (biopsy‐naïve men) or a repeat biopsy (prior‐negative biopsy men)
5 questions
OutcomeEffectEvidenceStatus / GRADE
Test result
no estimate extractedNRNo studies
True positives
no estimate extracted4 studies · 3421 participantsModerate
False negatives
no estimate extracted4 studies · 3421 participantsModerate
True negatives
no estimate extracted4 studies · 3421 participantsLow
False positives
no estimate extracted4 studies · 3421 participantsLow